Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Yang, Yi ^a   Jalal, Fakhreya Y ^a   Thompson, Jeffrey F ^a   Walker, Espen J ^b   Candelario Jalil, Eduardo ^a   Li, Lu ^a   Reichard, Ross R ^a   Ben, Chi ^c   Sang, Qing Xiang ^c   Cunningham, Lee Anna ^a   Rosenberg, Gary A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; GALACTOSYLCERAMIDE; GLUTATHIONE TRANSFERASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; CASPASE 3; GELATINASE B; STROMELYSIN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUOROMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REPERFUSION; WHITE MATTER; WILD TYPE; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; CYTOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAM PROTEINS; ANIMALS; BRAIN; BRAIN ISCHEMIA; CASPASE 3; CELL DEATH; FLUORESCENCE RESONANCE ENERGY TRANSFER; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; OLIGODENDROGLIA; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052079911     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-108     Document Type: Article

References (50)

1. Masumura M, Hata R, Nagai Y, et al. Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats. Neurosci Res 2001, 39:401-412. 10.1016/S0168-0102(01)00195-X, 11274739.
2. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab 2003, 23:263-274.
3. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004, 21:754-774. 10.1089/0897715041269641, 15253803.
4. Ness JK, Romanko MJ, Rothstein RP, et al. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors. Dev Neurosci 2001, 23:203-208. 10.1159/000046144, 11598321.
5. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27:1641-1646. 10.1161/01.STR.27.9.1641, 8784142.
6. Goldberg MP, Ransom BR. New light on white matter. Stroke 2003, 34:330-332. 10.1161/01.STR.0000054048.22626.B9, 12574526.
7. Tekkok SB, Goldberg MP. Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001, 21:4237-4248.
8. Selmaj K, Raine CS, Farooq M, et al. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 1991, 147:1522-1529.
9. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988, 23:339-346. 10.1002/ana.410230405, 3132891.
10. Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 2009, 87:264-280. 10.1016/j.pneurobio.2009.01.003, 19428957.
11. Crocker SJ, Whitmire JK, Frausto RF, et al. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am J Pathol 2006, 169:2104-2116. 10.2353/ajpath.2006.060626, 1762490, 17148673.
12. Smith MR, Kung H, Durum SK, et al. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997, 9:770-780. 10.1006/cyto.1997.0233, 9344510.
13. Wallace JA, Alexander S, Estrada EY, et al. Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury. J CerebBlood Flow Metab 2002, 22:1303-1310.
14. Wetzel M, Rosenberg GA, Cunningham LA. Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neurosci 2003, 18:1050-1060. 10.1046/j.1460-9568.2003.02838.x, 12956705.
15. Wetzel M, Li L, Harms KM, et al. Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia. Cell Death Differ 2008, 15:143-151. 10.1038/sj.cdd.4402246, 17962815.
16. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005, 50:329-339. 10.1002/glia.20169, 15846802.
17. Kokovay E, Li L, Cunningham LA. Angiogenic recruitment of pericytes from bone marrow after stroke. J CerebBlood Flow Metab 2006, 26:545-555.
18. Bongarzone ER, Howard SG, Schonmann V, et al. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J Neurosci 1998, 18:5344-5353.
19. Walker EJ, Rosenberg GA. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res 2010, 88:764-773.
20. Zhao BQ, Wang S, Kim HY, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006, 12:441-445. 10.1038/nm1387, 16565723.
21. Tamura Y, Kataoka Y, Cui Y, et al. Intracellular translocation of glutathione S-transferase pi during oligodendrocyte differentiation in adult rat cerebral cortex in vivo. Neuroscience 2007, 148:535-540. 10.1016/j.neuroscience.2007.06.026, 17681700.
22. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001, 81:871-927.
23. Buntinx M, Vanderlocht J, Hellings N, et al. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J Neurocytol 2003, 32:25-38.
24. Vinukonda G, Csiszar A, Hu F, et al. Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition. Brain 2010, 133:2264-2280. 10.1093/brain/awq107, 3139931, 20488889.
25. Skoff RP, Bessert DA, Barks JD, et al. Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Dev Neurosci 2001, 19:197-208. 10.1016/S0736-5748(00)00075-7, 11255033.
26. Deng Y, Lu J, Sivakumar V, et al. Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats. Brain Pathol 2008, 18:387-400. 10.1111/j.1750-3639.2008.00138.x, 18371179.
27. Huesmann GR, Clayton DF. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron 2006, 52:1061-1072. 10.1016/j.neuron.2006.10.033, 1847391, 17178408.
28. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005, 50:329-339. 10.1002/glia.20169, 15846802.
29. English JL, Kassiri Z, Koskivirta I, et al. Individual Timp deficiencies differentially impact pro-MMP-2 activation. J BiolChem 2006, 281:10337-10346.
30. Leco KJ, Waterhouse P, Sanchez OH, et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J ClinInvest 2001, 108:817-829.
31. Watanabe T, Zhang N, Liu M, et al. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 2006, 37:1539-1545. 10.1161/01.STR.0000221783.08037.a9, 16645134.
32. Kumar S, Biancotti JC, Yamaguchi M, et al. Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem Res 2007, 32:783-797. 10.1007/s11064-006-9208-6, 17186374.
33. Binder MD, Cate HS, Prieto AL, et al. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 2008, 28:5195-5206. 10.1523/JNEUROSCI.1180-08.2008, 18480276.
34. Matsubayashi Y, Iwai L, Toda T, et al. Immunostaining for oligodendrocyte-specific galactosphingolipids in fixed brain sections using the cholesterol-selective detergent digitonin. J Neurosci Methods 2009, 178:87-98. 10.1016/j.jneumeth.2008.11.018, 19100769.
35. See J, Zhang X, Eraydin N, et al. Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Mol Cell Neurosci 2004, 26:481-492. 10.1016/j.mcn.2004.04.004, 15276151.
36. Deng YY, Lu J, Ling EA, et al. Role of microglia in the process of inflammation in the hypoxic developing brain. Front Biosci (Schol Ed) 3:884-900.
37. Cammer W. Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000, 864:213-219. 10.1016/S0006-8993(00)02178-8, 10802028.
38. Kordek R, Nerurkar VR, Liberski PP, et al. Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci USA 1996, 93:9754-9758. 10.1073/pnas.93.18.9754, 38501, 8790403.
39. Smookler DS, Mohammed FF, Kassiri Z, et al. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 2006, 176:721-725.
40. Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007, 27:697-709.
41. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994. 10.1016/j.neuroscience.2008.06.025, 18621108.
42. Kim YS, Kim SS, Cho JJ, et al. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci 2005, 25:3701-3711. 10.1523/JNEUROSCI.4346-04.2005, 15814801.
43. Si-Tayeb K, Monvoisin A, Mazzocco C, et al. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006, 169:1390-1401. 10.2353/ajpath.2006.060005, 1780186, 17003494.
44. Choi DH, Kim EM, Son HJ, et al. A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem 2008, 106:405-415. 10.1111/j.1471-4159.2008.05399.x, 18397366.
45. D'Souza SD, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J ExpMed 1996, 184:2361-2370.
46. Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006, 26:12633-12641. 10.1523/JNEUROSCI.2801-06.2006, 17151265.
47. Akassoglou K, Bauer J, Kassiotis G, et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998, 153:801-813. 10.1016/S0002-9440(10)65622-2, 1853008, 9736029.
48. Jurewicz A, Matysiak M, Tybor K, et al. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 2005, 128:2675-2688. 10.1093/brain/awh627, 16219674.
49. Tekkok SB, Faddis BT, Goldberg MP. AMPA/kainate receptors mediate axonal morphological disruption in hypoxic white matter. Neurosci Lett 2005, 382:275-279. 10.1016/j.neulet.2005.03.054, 15925103.
50. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009, 8:280-291. 10.1016/S1474-4422(09)70043-2, 19233038.